Clinical Trials Browser

Active not recruiting × Disulfides × Plasma cell × Clear all

NCT05391750 2026-02-17

Venetoclax and Tocilizumab for the Treatment of Patients With Relapsed or Refractory t(11;14) Multiple Myeloma

Phase 1 Active not recruiting

Multiple Myeloma